NFKB1 and glioblastoma: GBM cells secrete receptor activator of nuclear factor kappa beta ligand (RANKL), activating the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) pathway in astrocytes, promoting tumor invasiveness [149].